Kalbe Farma Sustainability Profile
Kalbe Farma, officially known as PT Kalbe Farma Tbk, is a leading pharmaceutical company headquartered in Indonesia. Established in 1966, Kalbe Farma has grown to become a prominent player in the healthcare industry, with a strong presence across Southeast Asia. The company focuses on various sectors, including prescription pharmaceuticals, consumer health products, and nutritional supplements. Kalbe Farma is renowned for its innovative approach to healthcare, offering a diverse range of products such as over-the-counter medications, herbal remedies, and advanced nutritional solutions. Its commitment to quality and research has positioned it as a trusted name in the market, achieving significant milestones in product development and distribution. With a robust market position, Kalbe Farma continues to enhance the well-being of communities through its comprehensive healthcare solutions.
DitchCarbon Score
How does Kalbe Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kalbe Farma's score of 28 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kalbe Farma's reported carbon emissions
In 2023, Kalbe Farma reported total carbon emissions of approximately 94,015,170 kg CO2e, comprising 18,484,770 kg CO2e from Scope 1 emissions and 75,530,400 kg CO2e from Scope 2 emissions. This represents a significant reduction from 2022, where total emissions were about 122,326,800 kg CO2e, with Scope 1 emissions at 24,392,200 kg CO2e and Scope 2 emissions at 97,934,590 kg CO2e. The company has consistently disclosed its emissions data for Scope 1 and Scope 2, but has not reported any Scope 3 emissions. Over the years, Kalbe Farma has shown a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been detailed in the available data. Kalbe Farma's emissions data is sourced directly from the company, PT Kalbe Farma Tbk., and does not appear to be cascaded from any parent organisation. The company continues to focus on transparency in its sustainability reporting, aligning with industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 14,233,290 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 63,725,950 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Kalbe Farma's Industry?
How Carbon Intensive is Kalbe Farma's Location?
Kalbe Farma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kalbe Farma has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
